The knowledge about the molecular alterations which are found in head and neck squamous cell carcinomas (HNSCC) has much increased in recent years
The knowledge about the molecular alterations which are found in head and neck squamous cell carcinomas (HNSCC) has much increased in recent years. evidence related to the role of Wnt signaling activation in the stimulation of cell proliferation, migration and inhibition of apoptosis in HNSCC is presented. Moreover, its role in promoting stemness traits in head and neck cancer stem-like cells is described. Evidence corroborating the hypothesis that the Wnt signaling pathway is a very promising target of novel therapeutic interventions in HNSCC is also discussed. WDR5-0103 mutations and mutations were present infrequently [10,11,12,13,14,15,16]. The mutations of tumor suppressor, which WDR5-0103 encodes a protocadherin protein that binds and inactivates -catenin, were WDR5-0103 detected in some cases of HNSCC [17]. However, the activation of the Wnt/-catenin pathway in HNSCC seems to be more prevalent than it is suggested by genetic findings, due to cross-talk with other molecular alterations, which can lead to pathway cross-activation. Indeed, it has been shown that -catenin can be activated via enhanced EGFR or PI3K signaling, which belong to the most frequently dysregulated signaling pathways in HNSCC. In this regard, elevated EGFR expression was associated with delocalized -catenin expression [13]. In another study, the nuclear translocation of -catenin correlated with high expression of EGFR in oral squamous cell carcinoma (OSCC) samples [18]. The stabilization of membrane-bound EGFR by preventing its endocytosis might lie behind galectin-mediated stimulation of Wnt/-catenin pathway activity [19]. Other studies show that galectin-3-mediated induction from the Wnt pathway resulted from Akt-dependent phosphorylation and inactivation of GSK-3 [20]. The treating OSCC cells with epidermal development element improved the known degree of phosphorylation of -catenin at tyrosine residues, resulting in its dissociation from E-cadherin and nuclear translocation. It stimulated -catenin-dependent reporter gene manifestation [18] also. Additionally, inside a scholarly research for the immortalization of major dental keratinocytes, the intro of a mutated edition of (p53R(175)H missesnse mutation) resulted in a substantial induction of the gene manifestation profile coordinating Wnt/-catenin pathway activation [21]. The central regulatory proteins in the WDR5-0103 canonical Wnt pathway can be -catenin. Quickly, in unstimulated cells, cytoplasmic -catenin undergoes proteasomal degradation, which is stimulated by its phosphorylation by the components of the destruction complex, which comprises casein kinase 1 (CK1), GSK-3, APC and AXIN (Figure 1). On the other hand, when extracellular Wnt ligands bind to Frizzled (FZD) and LRP receptors, they lead to the inhibition of the destruction complex, and the stabilization of cytoplasmic -catenin, which may subsequently translocate to the nucleus. In the nucleus, -catenin binds to TCF/LEF Rabbit polyclonal to SGK.This gene encodes a serine/threonine protein kinase that is highly similar to the rat serum-and glucocorticoid-induced protein kinase (SGK). transcription factors and induces the expression of target genes, which regulate cell survival, proliferation, cell migration and apoptosis (Figure 2) [22]. Open in a separate window Figure 1 The fates of -catenin, when the canonical Wnt pathway is not activated. Extracellular Wnt ligands are sequestered by antagonistic proteins (SFRPs, WIF1) and cannot bind to FZD/LRP receptors. Membrane-bound -catenin takes part in cell-cell adhesion, together with E-cadherin and -catenin. Cytoplasmic -catenin is phosphorylated by the components of the destruction complex (CK, GSK-3) and targeted for ubiquitin-mediated proteasomal degradation, and thus cannot translocate to nucleus and activate transcription. TCF/LEF WDR5-0103 transcription factors form complexes with suppressors of -catenin-dependent transcription (e.g., Groucho) and cannot stimulate the expression of WRE-regulated genes. WREWnt response element, CKcasein kinase 1. Open in a separate window Figure 2 The activation of the canonical Wnt pathway in head and neck cancers is mediated by various factors. The synthesis of Wnt ligands is enhanced, which is related to the elevated activity of enzymes responsible for post-translational modificationsglycosylation and palmitoylation. The increased activity of Wnt ligands results from the reduced expression of extracellular Wnt antagonists. After secretion, Wnt ligands activate FZD/LRP receptors, which destabilizes the destruction complex, which can no longer phosphorylate -catenin and stimulate its degradation. The destabilization of the destruction complex may also be mediated by the activation/overexpression of other molecular factors (e.g., EGFR, PI3K, c-MET, CIP2A), including HPV infection (details provided in the text). The resulting translocation of -catenin to the nucleus activates TCF/LEF-mediated.
